Coronavirus Baricitinib reduces deaths in patients hospitalised with COVID-19 British Reporter– The RECOVERY trial has demonstrated that baricitinib reduces the risk of death when given to hospitalised patients with severe COVID-19. More by British Reporter March 4, 2022 7 mins read